Their study showed that genetic variants of HMGCR that lowered LDL cholesterol in 129,170 individuals from randomized trials increased the risk of T2D (OR 1.12, 95% CI, 1.06–1.18). Here, HMGCR is linked to type 2 diabetes mellitus.